BioPharm International
March 15, 2018
Features
2018 eBook
1
The author reviews operative options for the implementation of a quality oversight and how companies can benefit from this function from a regulatory perspective.
March 15, 2018
Features
2018 eBook
1
Drug manufacturers can improve use of quality agreements in contract manufacturing.
March 15, 2018
Features
2018 eBook
1
Contract testing organizations can provide bio/pharma companies with a cost-effective way to adapt to new technologies and regulations.
March 15, 2018
Features
2018 eBook
1
A review of the latest investments in facilities, equipment, and acquisitions by biopharma contract service providers.
March 15, 2018
Features
2018 eBook
1
Process validation is an extension of biologics development processes.
March 15, 2018
Features
2018 eBook
1
A different perspective on controlling fixed costs of biomanufacturing, based on know-how from other industries, provides a competitive edge, says the CEO of Samsung BioLogics.
March 15, 2018
Features
2018 eBook
1
Successful outsourcing relationships for early phase analytics in drug development are driven by partnership.
March 15, 2018
Features
2018 eBook
1
Research suggests that working with a single contract partner can reduce development time and improve economics.
February 01, 2018
Features
2018 eBook
1
CRLs put the brakes on drug development and damage corporate reputation and stock prices. Upfront investment and better sponsor oversight are ways to prevent them.